Celox Rapid has been developed with unique, patented technology, in response to the real needs of battlefield medics and represents the next stage in not only the development of the original Celox, which is already standard issue for the UK military but sets a new standard for haemostatic agents/control.

Advertisement

In combat scenarios, time is very much of the essence in cases of severe bleeding caused by gunshot wounds or explosions. The injured soldier has to be treated and evacuated from the scene as fast as possible; even a matter of minutes can be too long. Celox Rapid can control the most serious, life-threatening bleeding with just 60 seconds compression.

Easily carried in a slim-line pack, Celox Rapid comes in a strip of Z-fold gauze onto which Celox granules and Chito-R are bonded. The Chito-R, one of the distinguishing features of Celox Rapid, creates a unique adhesion (wet stick) to the source of the bleeding and works with the Chitosan already in the Celox to create a gel-like plug that stops the bleeding faster than any other treatment.

Advertisement

The Celox blood clotting technology was first developed by MedTrade precisely for the purpose of dealing with battlefield wounds and has been tried and tested in both Afghanistan and Iraq. Working independently of the body’s normal clotting processes, Celox generates no heat and does not burn the casualty or care giver. It has also been proven effective in situations where the blood does not clot normally, for example in cases of shock-induced hypothermia and in the presence of common anti-coagulants such as warfarin.

Chris Marsden, head of marketing for Celox said: “Speed is absolutely paramount in casualty care and Celox Rapid offers a radical change in the ability to deliver fast, effective treatment. Celox Rapid has had a great reception in the US and is already generating a huge amount of interest since its launch in Europe. We are very proud to support NATO troops and the emergency services with this new development.”

Advertisement